1-3 of 3
Alexander Wacker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective, Open-Label, Multicenter, Phase 2 Trial to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib (ONO/GS-4059) and Entospletinib with and without Obinutuzumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Nadine Kutsch, MD, Christian Pallasch, Eugen Tausch, Volkmar Boehme, Matthias Ritgen, Ruediger Liersch, Alexander Wacker, Georg Jacobs, Ralf Ulrich Trappe, Peter Dreger, Stephan Stilgenbauer, Danjie Zhang, Juliane M. Jürgensmeier, Pankaj Bhargava, Michael Hallek, Barbara F. Eichhorst, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4297.
https://doi.org/10.1182/blood-2019-130912
Published: 2019
Journal Articles

CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells

Tina Baessler, Jean Enno Charton, Benjamin Joachim Schmiedel, Frank Grünebach, Matthias Krusch, Alexander Wacker, Hans-Georg Rammensee, Helmut Rainer Salih
Journal: Blood
Blood (2010) 115 (15): 3058–3069.
https://doi.org/10.1182/blood-2009-06-227934
Published: 2010
Journal Articles

Consequences of 4-1BB-4-1BB Ligand Interaction for NK Cell Anti-Tumor Immunity: Opposite Effects of Seemingly Analogue Molecules in Mice and Men.

Tina Baessler, Jean E Charton, Corina Buechele, Benjamin J Schmiedel, Frank Gruenebach, Matthias Krusch, MD, Alexander Wacker, Lothar Kanz, MD, Helmut R Salih, MD
Journal: Blood
Blood (2009) 114 (22): 279.
https://doi.org/10.1182/blood.V114.22.279.279
Published: 2009